Patents Assigned to Kura Oncolofy, Inc.
  • Methods of treating cancer with farnesyltransferase inhibitors
    Patent number: 10426767
    Abstract: The present invention relates to the field of cancer therapy. Specifically, provided are methods of treating cancer, for example, peripheral T-cell lymphoma (“PTCL”), with a farnesyltransferase inhibitor (FTI) that include determining whether the subject is likely to be responsive to the FTI treatment based on gene expression characteristics.
    Type: Grant
    Filed: April 5, 2018
    Date of Patent: October 1, 2019
    Assignee: Kura Oncolofy, Inc.
    Inventors: Antonio Gualberto, Catherine Rose Scholz